Optimization of bone-tissue engineering in goats

被引:37
作者
Kruyt, MC
Dhert, WJA
Oner, C
van Blitterswijk, CA
Verbout, AJ
de Bruijn, JD
机构
[1] Univ Utrecht, Med Ctr, Dept Orthoped, NL-3508 GA Utrecht, Netherlands
[2] IsoTis NV, Bilthoven, Netherlands
关键词
tissue engineering; serum; extracellular matrix; bone; ectopic; goats; cells;
D O I
10.1002/jbm.b.10073
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Successful bone-tissue engineering (TE) has been reported for various strategies to combine cells with a porous scaffold. In particular, the period after seeding until implantation of the constructs may vary between hours and several weeks. Differences between these strategies can be reduced to (a) the presence of extracellullar matrix, (b) the differentiation status of the cells, and (c) the presence of residual potentially immunogenic serum proteins. These parameters are investigated in two types of calcium phosphate scaffolds in a goat model of ectopic bone formation. Culture-expanded bone-marrow stromal cells from eight goats were seeded onto two types of hydroxyapatite granules: HA60/400 (60% porosity, 400-mum average pore size) and HA70/800. Scaffolds seeded with cells and control scaffolds were cultured for 6 days in medium containing autologous or semisynthetic serum, in the presence or absence of dexamethasone. Other scaffolds were seeded with cells just before implantation in medium with or without serum. All conditions were implanted autologously in the paraspinal muscles. After 12 weeks, bone had formed in 87% of all TE constructs, as demonstrated by histology. Histomorphometry indicated significantly more bone in the HA70/800 scaffolds. Furthermore, a significant advantage in bone formation was found when the constructs had been cultured for 6 days. In conclusion, both scaffold characteristics (porosity) and TE strategy (culturing of the constructs) were demonstrated to be important for bone TE. (C) 2004 Wiley Periodicals, Inc.
引用
收藏
页码:113 / 120
页数:8
相关论文
共 38 条
[1]   Association of porous hydroxyapatite and bone marrow cells for bone regeneration [J].
Anselme, K ;
Noël, B ;
Flautre, B ;
Blary, MC ;
Delecourt, C ;
Descamps, M ;
Hardouin, P .
BONE, 1999, 25 (02) :51S-54S
[2]   Bone regeneration by implantation of purified, culture-expanded human mesenchymal stem cells [J].
Bruder, SP ;
Kurth, AA ;
Shea, M ;
Hayes, WC ;
Jaiswal, N ;
Kadiyala, S .
JOURNAL OF ORTHOPAEDIC RESEARCH, 1998, 16 (02) :155-162
[3]   The effect of implants loaded with autologous mesenchymal stem cells on the healing of canine segmental bone defects [J].
Bruder, SP ;
Kraus, KH ;
Goldberg, VM ;
Kadiyala, S .
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 1998, 80A (07) :985-996
[4]   MESENCHYMAL STEM-CELLS [J].
CAPLAN, AI .
JOURNAL OF ORTHOPAEDIC RESEARCH, 1991, 9 (05) :641-650
[5]  
CARMICHAEL J, 1987, CANCER RES, V47, P936
[6]  
COULSON RA, 1983, PERSPECT BIOL MED, V27, P121
[7]  
DEBRUIJN JD, 1998, BIOCERAMICS, V11, P497
[8]  
DELEU J, 1965, J Bone Joint Surg Br, V47, P319
[9]  
Dennis J E, 1992, Cell Transplant, V1, P23
[10]   In vivo osteogenesis assay: a rapid method for quantitative analysis [J].
Dennis, JE ;
Konstantakos, EK ;
Arm, D ;
Caplan, AI .
BIOMATERIALS, 1998, 19 (15) :1323-1328